2 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
Follow Neurodevelopment Outcome: new trials by email Literature Review of Neurodevelopment Outcome trials Research Report on Neurodevelopment Outcome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study Iron (60 mg)- folic acid (400 ug) [IFA], Multiple micronutrient supplement [MMS], Multiple micronutrient supplement Plus [MMS+] - Neurodevelopment Outcome, Linear Growth | Phase 3 | Recruiting | Johns Hopkins Bloomberg School of Public Health | 3000 | 2026-09-27 | 2026-10-09 |
| The MOM-CARE Trial : Evaluating Antenatal and Postnatal MMSPlus for Improved Infant Birth and Growth Outcomes MMS, MMS Plus, IFA - Newborn Health, Multiple Micronutrient Deficiencies During Pregnancy | Phase 3 | Recruiting | Aga Khan University | 3000 | 2025-07-08 | 2025-10-07 |
Growth Disorders (1) · Thinness (1)
Body Weight (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Folic Acid (1) · Iron (1)
Aga Khan University (1) · Johns Hopkins Bloomberg School of Public Health (1)
Bangladesh (1) · Pakistan (1)
Fyezah Jehan, MBBS; MSc (1) · Parul Christian, DrPH (1)